131 related articles for article (PubMed ID: 18360056)
1. Pioglitazone, a thiazolidinedione derivative, attenuates left ventricular hypertrophy and fibrosis in salt-sensitive hypertension.
Nakamoto M; Ohya Y; Shinzato T; Mano R; Yamazato M; Sakima A; Takishita S
Hypertens Res; 2008 Feb; 31(2):353-61. PubMed ID: 18360056
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats.
Shinzato T; Ohya Y; Nakamoto M; Ishida A; Takishita S
Hypertens Res; 2007 Sep; 30(9):863-73. PubMed ID: 18037780
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.
Kato MF; Shibata R; Obata K; Miyachi M; Yazawa H; Tsuboi K; Yamada T; Nishizawa T; Noda A; Cheng XW; Murate T; Koike Y; Murohara T; Yokota M; Nagata K
J Hypertens; 2008 Aug; 26(8):1669-76. PubMed ID: 18622247
[TBL] [Abstract][Full Text] [Related]
4. Effects of pioglitazone on high-fat-diet-induced ventricular remodeling and dysfunction in rats.
Tian YQ; Li SS; Su XD; Zhang GZ; Zhao JJ; Li GW; Wang L
J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):223-8. PubMed ID: 22031275
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy.
Elrashidy RA; Asker ME; Mohamed HE
J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):324-33. PubMed ID: 22261714
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.
Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Noda A; Izawa H; Nagata K; Yokota M
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1164-71. PubMed ID: 17184496
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
[TBL] [Abstract][Full Text] [Related]
8. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure.
Ichihara S; Noda A; Nagata K; Obata K; Xu J; Ichihara G; Oikawa S; Kawanishi S; Yamada Y; Yokota M
Cardiovasc Res; 2006 Feb; 69(3):726-35. PubMed ID: 16165109
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
[TBL] [Abstract][Full Text] [Related]
10. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M
Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of salt-sensitive hypertension in Dahl rats reveals a link between cardiac fibrosis and high cholesterol.
Wendt N; Schulz A; Qadri F; Bolbrinker J; Kossmehl P; Winkler K; Stoll M; Vetter R; Kreutz R
Cardiovasc Res; 2009 Feb; 81(3):618-26. PubMed ID: 18824493
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of the combination of nifedipine and losartan in hypertensive Dahl salt-sensitive rats.
Tinel H
J Cardiovasc Pharmacol; 2007 Jul; 50(1):75-82. PubMed ID: 17666919
[TBL] [Abstract][Full Text] [Related]
13. Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats.
Kobayashi N; Nishikimi T; Horinaka S; Ishimitsu T; Matsuoka H
Atherosclerosis; 2001 Jun; 156(2):255-65. PubMed ID: 11395021
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in Zucker obese rats fed a high-protein diet.
Namikoshi T; Tomita N; Satoh M; Haruna Y; Kobayashi S; Komai N; Sasaki T; Kashihara N
Hypertens Res; 2008 Apr; 31(4):745-55. PubMed ID: 18633187
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
[TBL] [Abstract][Full Text] [Related]
16. Effects of pioglitazone on cardiac and adipose tissue pathology in rats with metabolic syndrome.
Matsuura N; Asano C; Nagasawa K; Ito S; Sano Y; Minagawa Y; Yamada Y; Hattori T; Watanabe S; Murohara T; Nagata K
Int J Cardiol; 2015 Jan; 179():360-9. PubMed ID: 25464487
[TBL] [Abstract][Full Text] [Related]
17. High salt intake accelerated cardiac remodeling in spontaneously hypertensive rats: time window of left ventricular functional transition and its relation to salt-loading doses.
Gao F; Han ZQ; Zhou X; Shi R; Dong Y; Jiang TM; Li YM
Clin Exp Hypertens; 2011; 33(7):492-9. PubMed ID: 21529316
[TBL] [Abstract][Full Text] [Related]
18. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.
Yamamoto K; Masuyama T; Sakata Y; Nishikawa N; Mano T; Yoshida J; Miwa T; Sugawara M; Yamaguchi Y; Ookawara T; Suzuki K; Hori M
Cardiovasc Res; 2002 Jul; 55(1):76-82. PubMed ID: 12062710
[TBL] [Abstract][Full Text] [Related]
19. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
Nagata K; Somura F; Obata K; Odashima M; Izawa H; Ichihara S; Nagasaka T; Iwase M; Yamada Y; Nakashima N; Yokota M
Hypertension; 2002 Aug; 40(2):168-74. PubMed ID: 12154108
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan.
Nakamura T; Yamamoto E; Kataoka K; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
Hypertension; 2008 Feb; 51(2):296-301. PubMed ID: 18158350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
